查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1411355

肛门瘘治疗市场：按治疗类型、瘻管类型、最终用户划分 - 全球预测 2024-2030

Anal Fistula Treatment Market by Treatment Type (Non-Surgical, Surgical), Fistula Type (Intersphincteric Fistula, Suprasphincteric Fistula, Transsphincteric Fistula), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年肛瘘治疗市场规模为6.5139亿美元，预计2024年将达6.7552亿美元，2030年将达9.091亿美元，复合年增长率为4.87%。

全球肛门瘘治疗市场

主要市场统计
基准年[2023] 65139万美元
预测年份 [2024] 67552万美元
预测年份 [2030] 9.091 亿美元
复合年增长率（%） 4.87%
肛门瘘治疗市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估肛门瘘治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对肛瘘治疗市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-肛瘘治疗市场的市场规模与预测是多少？

2-在肛瘘治疗市场的预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-肛瘘治疗市场的技术趋势和法律规范是什么？

4-肛瘘治疗市场主要厂商的市场占有率是多少？

5-进入肛瘘治疗市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球肛门瘘盛行率上升
      • 微创手术趋势
      • 提高肛瘘治疗药物和治疗方法的核准率
    • 抑制因素
      • 肛瘘治疗费用高
    • 机会
      • 肛瘘治疗方法介绍
      • 用于开发增强药物和治疗方法的大量投资和资金
    • 任务
      • 肛瘘治疗相关的复杂问题
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章肛瘘治疗市场：依治疗类型

  • 非手术的
  • 外科

第七章肛瘘治疗市场：按瘻管类型

  • 括约肌间瘻管
  • 括约肌上瘻管
  • 经括约肌瘻

第八章肛瘘治疗市场：依最终使用者分类

  • 门诊手术中心
  • 医院

第九章 北美和南美肛门瘘治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太肛瘘治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲肛门瘘治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Cook Group Incorporated
    • Integra LifeSciences Corporation
    • Johnson & Johnson Services, Inc.
    • KARL STORZ SE & Co. KG
    • Novartis AG
    • Pfizer Inc.
    • Signum Surgical
    • Surtex Instruments Limited
    • Takeda Pharmaceutical Company Limited
    • THD SpA
    • WL Gore & Associates, Inc.
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-8E22B61932E1

[180 Pages Report] The Anal Fistula Treatment Market size was estimated at USD 651.39 million in 2023 and expected to reach USD 675.52 million in 2024, at a CAGR 4.87% to reach USD 909.10 million by 2030.

Global Anal Fistula Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 651.39 million
Estimated Year [2024] USD 675.52 million
Forecast Year [2030] USD 909.10 million
CAGR (%) 4.87%
Anal Fistula Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anal Fistula Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anal Fistula Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anal Fistula Treatment Market, highlighting leading vendors and their innovative profiles. These include Cook Group Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Novartis AG, Pfizer Inc., Signum Surgical, Surtex Instruments Limited, Takeda Pharmaceutical Company Limited, THD SpA, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Anal Fistula Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Type
    • Non-Surgical
    • Surgical
  • Fistula Type
    • Intersphincteric Fistula
    • Suprasphincteric Fistula
    • Transsphincteric Fistula
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anal Fistula Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anal Fistula Treatment Market?

3. What are the technology trends and regulatory frameworks in the Anal Fistula Treatment Market?

4. What is the market share of the leading vendors in the Anal Fistula Treatment Market?

5. Which modes and strategic moves are suitable for entering the Anal Fistula Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anal Fistula Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of anal fistula among individuals worldwide
      • 5.1.1.2. Inclination towards minimally invasive surgical procedure
      • 5.1.1.3. Rise in approval rate for drugs and therapies for anal fistula treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of anal fistula treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel treatments for anal fistula
      • 5.1.3.2. Significant investment and funding for development of enhanced drugs and treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with anal fistula treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anal Fistula Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Non-Surgical
  • 6.3. Surgical

7. Anal Fistula Treatment Market, by Fistula Type

  • 7.1. Introduction
  • 7.2. Intersphincteric Fistula
  • 7.3. Suprasphincteric Fistula
  • 7.4. Transsphincteric Fistula

8. Anal Fistula Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Anal Fistula Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Anal Fistula Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Anal Fistula Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Cook Group Incorporated
    • 13.1.2. Integra LifeSciences Corporation
    • 13.1.3. Johnson & Johnson Services, Inc.
    • 13.1.4. KARL STORZ SE & Co. KG
    • 13.1.5. Novartis AG
    • 13.1.6. Pfizer Inc.
    • 13.1.7. Signum Surgical
    • 13.1.8. Surtex Instruments Limited
    • 13.1.9. Takeda Pharmaceutical Company Limited
    • 13.1.10. THD SpA
    • 13.1.11. W. L. Gore & Associates, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANAL FISTULA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ANAL FISTULA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANAL FISTULA TREATMENT MARKET DYNAMICS
  • FIGURE 7. ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANAL FISTULA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANAL FISTULA TREATMENT MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANAL FISTULA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. ANAL FISTULA TREATMENT MARKET SIZE, BY INTERSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANAL FISTULA TREATMENT MARKET SIZE, BY SUPRASPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANAL FISTULA TREATMENT MARKET SIZE, BY TRANSSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. ANAL FISTULA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANAL FISTULA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. ANAL FISTULA TREATMENT MARKET LICENSE & PRICING